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Abstract
Cancer cell research has been growing for decades. In the field of cancer pathology, there
is an increasing and long-unmet need to develop a new technology for low-cost, rapid, sensitive,
selective, label-free (i.e. direct), simple and reliable screening, diagnosis, and monitoring of live
cancerous and normal cells in same (or similar) shape and size from the same anatomic region. For
the first time based on an electrochemical impedance signal, the breast cancer and normal cells
have been thus screened, diagnosed and monitored on a smart bioscaffold of entangled nanowires
of bioceramics titanate. The bioscaffold was grown and self-assembled directly on the surface of
implantable Ti-metal following a patent from Tian-lab, and characterized by means of SEM, XRD,
etc. On the smart bioscaffold in aqueous solutions of phosphate buffer saline (PBS), human breast
benign (MCF7) and aggressive (MDA-MB231) cancer cells, normal (MCF10A) cells, and colon
cancer cells (HCT116) showed characteristic impedance highly different than that of the blank
sensor. For two sets of mixtures each mixing the normal and cancer cells, the impedance signals
have shifted linearly with the wide range of mixing ratios, showing the biosensor’s selectivity and
reliability. After being treated with glucose and chemotherapeutic drug (i.e. doxorubicin or DOX),
different breast cancer cells showed different impedance signals from their difference in glucose
metabolisms (i.e. Warburg Effect) and in resistances to the Dox, thus-fingerprinting the cells
easily. Based on the nanostructure chemistry, impedance equivalent circuitry and cancer cell
biology, it’s the different cells surface binding on the nanowires, and different cancer cells
metabolic wastes from the different treatments on the nanowires that changed the charge density
on the scaffolding nanowire surface and in turn changed the impedance signals. This new sensor
is believed generally expandable to quantifying and characterizing live cells and even biological
tissues of different types in future.
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PART I
Chapter 1. Introduction

1.1 Overview of Current Cancer Diagnosis and Research
Breast cancer patients have been increasing in number causing a high health threat
worldwide. According to the American Cancer Society, breast cancer is the most common noncutaneous cancer in women in the US. Breast cancer has a 14% mortality rate among women and
the rate is the second highest among all types of cancer.1 Current diagnostic technology utilizes a
combination of radiological, surgical, and pathologic assessments. Diagnosis of breast cancer is
routinely done by mammogram, but it cannot distinguish between benign and malignant lesions.
Mammogram also fails to detect 10% to 25% of breast cancers, because tumor detection is difficult
in dense breast tissue.2 A biopsy is also needed to confirm or role out cancer, and it requires
significant sample preparation using bench top protocols. PCR and flow cytometry also have been
used for detecting circulating cancer cells in the blood and may predict the survival rate.3 However,
both techniques require using specific tagging system and identifying particular markers, which
may not be expressed in some cancer subpopulations. Also, they lead to cell destruction and loss
of cell viability. Therefore, there is a high demand to solve this issue by developing further
advanced technology to improve sensitivity and selectivity in breast cancer detection. The
technology should also be simple, efficient, and inexpensive.
Recently, nanowire material has attracted attention as an excellent material to be used in
biosensing technology. This is due to their unique properties of being semiconducting with high
sensitivity to detect single molecule.4 Titanium oxide (TiO2)-based semiconductor nanowires can
be grown on top of titanium metal and, in turn, it can be used as an electrode to sense cancer
cells. These TiO2 nanowires have a band gap between 1.8 and 4.1 eV. This range reflect a
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semiconductor property making them unique from other nanowires by having the best sensitivity
ranges.123 Besides, TiO2-nanowires are easily fabricated, highly biocompatible and chemically
more stable.5 Thus, TiO2-nanowires are ideal for sensing purposes.
1.2 The Importance and Motivation
In this study, TiO2 nanowires were used for the development of a label-free
electrochemical biosensor on a bio-scaffold for direct detection of different live breast cancer
cell lines (MCF7 and MDA-MB231) in vitro. Cancer cells exhibit altered local dielectric
properties compared to normal cells.40 They have different electrical conductance and
capacitance, which can be measured by electrical impedance scanning (EIS). Therefore, these
observations open a new direction toward using the electrochemical properties of cancer cells
and apply them to help in developing a prognostic tool for future diagnostic technology. This
new method also can be potentially used in various important applications in cancer screening
and monitoring, which are doable in vitro at ultra-low-cost and in real-time.
1.3 Dissertation Structure
This dissertation consists of eight chapters. In chapter one, the introduction; it consists of
a brief overview of current cancer diagnostic tool and the significance of this study within this
field.
Chapter two, overview of cell membrane and cell metabolism, where it begins by
explaining the function of the cells and the mass transfer across its biomembranes. The
biomembranes structure and the surface charge influence on its functionality.
Chapter three, impedance cell biosensing based on nanomaterial, describes the history of
using bioimpedance to determine the pathological tissue stage. Further, introducing nanomaterial
and their applications in biosensing, specifically the TiO2- nanowire that has been used in this
research.
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Chapter four, characterization methods, an introductory about the working principles of
instruments being used in this project. Chapter five, materials and methods, a full explanation of
the required chemicals, material and the instrumentation and the equivalent circuitry that has
been used, which will be presented and thoroughly explained. In chapter six, results and
discussion and the sensing of cells by TiO2-nanowire and the interpretation of the results will be
discussed in detail.
Chapter seven, summarize the experimental results and conclusion. Chapter eight, the
future work; some projects are proposed to be conducted by any interested graduate student or
researchers in this field.
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Chapter 2. Overview of Cell membrane and Metabolism
2.1 Cell Structure and Its Function
2.1.1 Cell membrane structure
A cell is the smallest structural and functional biological system of an organism. It
consists of cytoplasm and a nucleus surrounded by a plasma membrane. It can be classified into
two categories: prokaryotic and eukaryotic. Prokaryotes can be distinguished by lacking a true
nucleus such as in bacteria, where it can be found in animal, plant, and fungi cells. Cells differ in
size and shapes, for example, bacteria are around 1-5 µm, while animal cells are around 10-100
µm in diameter. Cell membrane have the main role in transporting biomolecules across its plasma
membrane, which is related to the ratio of surface area to the volume which is quite large 6.
The plasma membrane is the most common structure among cells, giving the cell its
shape and protecting its organelles. Moreover, it controls the traffic of biomolecules and ions
across it and it has an important role in initiating certain signaling pathways and cascades to
activate or inhibit certain cells activity in response to the external environment. It composes of
two (4-5 nm in thickness) phospholipids layers arranging them self by having the polar head
groups directed toward the outer and the inner membrane surrounding polar solution such as
water, while having the hydrophobic two fatty acids (nonpolar) tails imbedded within the interior
of the membrane, thus exhibiting amphipathic nature (Fig. 2.1) 7. The hydrocarbon chains play
an essential role in maintaining cell fluidity and stability. Higher number of saturated chains
(having single bonds) give more rigidity to the membrane, while kinks (double-bond between
hydrocarbon chain will interfere with fatty acid packing resulting in a decrease in rigidity
(increase the fluidity of the membrane). In general, biomembranes consists of different kind of
phospholipids such as Phosphatidylcholine (lecithin) (PC), Phosphatidylethanolamine (cephalin)
(PE), Phosphatidylserine (PS), Phosphatidylinositol (PI), and Sphingomyelin (SM). Moreover,
4

cell membrane contains glycolipids, cholesterol, and membrane proteins. Membrane proteins
have an important role in transportation, attachment, recognition, and signal transactions. 6

Figure 2.1: Illustration of a cross section of cell membrane and its major components.

2.1.2 Transportation across the biomembranes
The plasma membrane is responsible for maintaining the hemostasis of cell by creating a
barrier separating the cell from the exterior environment and allowing specific biomolecules to
bypass into the cell cytoplasm keeping specific concentration and composition.8 Due to its dense
hydrophobic core, the plasma membrane phospholipids bilayer is impermeable to water-soluble
molecules and ions. Only gases, such as oxygen (O2) and carbon dioxide (CO2) along with small
uncharged polar molecules, such as ethanol and urea can move freely by simple diffusion across
the artificial pure phospholipid membrane or phospholipid mixed with cholesterol. These
molecules can diffuse without the need of a protein carrier and thus no energy is consumed.
Thus, the movement is down the chemical concentration gradient (the higher the concentration
gradient of the substance, the faster the movement rate across the membrane). Ionic molecules
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movement is controlled by electrochemical potential (gradient), which include both the
concentration gradient and the charge gradient across the membrane.
Most cells’ membranes have a negative potential, meaning that the outside of the
membrane have higher potential than inside.7 The excess in the negative charges inside the cell is
due to the presence of the negatively charged proteins, even with the presence of more potassium
ions concentrating inside the cell (~150mM inside to ~4mM outside).9 In contrast, the outer side
of the membrane has higher potential due to the high concentration of sodium (~140 mM outside
to ~5 mM inside) and other cations, such as calcium, creating a higher potential (more positive).8
Ion transportation across the membrane or between its cellular compartment is mediated
by specialized membrane proteins which are transmembrane proteins composed of multiple
membrane- spanning segments (mainly alpha helices). Such transmembrane proteins facilitate
the movement of hydrophilic substances, such as ions without being in contact with the
hydrophobic part of the membrane. The protein membrane transporter is being classified into
three main groups: ATP-powered pumps, ions channels, and transporters.
ATP-powered pumps are ATPases uses the ATP hydrolysis to get the energy to be able to
move ions or small molecules either against the concentration gradient or the charge gradient, or
both. This process is also known as “active transport”. Ion Channels transfer ions down their
concentration gradient without energy consumption and this also is known as “passive
transport”, facilitative transport, or non-gating”. However, most ion channels are controlled by
specific chemical or electrical signal and are referred to as “gated channels”. In fact, like all other
transporter proteins, ion channels are selective to the type of molecule they transport.8
The third type of protein transporters, are also called “carriers”, moving a wide variety of
ions and molecules but in lower rate compared to ion channels. It is further classified into three
main types: Uniporter (facilitated transporter), antiporter, and symporters. Uniporter transfer a
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single type of molecule down its concentration gradient. Glucose and amino acids are transported
with the aid of uniporter. On the contrary, antiporters and symporters facilitate the movement of
one type of ions against concentration gradient with the movement of another ion down its
concentration gradient either in the same direction (symporters) or in the opposite direction
(antiporters). Both types can also be referred as “cotransporters” due to their ability to transport
two or more molecules at the same time.8
2.2 Normal vs Cancer Cell Metabolism
2.2.1 Normal cell metabolism
In multicellular organisms, such as human body, cells are surrounded by blood vessels
carrying a constant nutrient supply. Proliferation regulation is crucial to the human body survival
especially when the nutrient level exceeds the need for cell division. Therefore, uncontrolled cell
division is prevented by inhibiting taking up nutrient unless stimulated by stimulator, such as
growth factor. However, cancer cells overcome this regulation by altering receptor-initiated
growth factor. Studies have shown growing evidence that some of the cellular pathways have
constantly been activated the nutrient uptake promoting cell survival and growth.10, 11
In mammalian cells, glucose is the primary source of energy and play an essential role in
cell metabolism. Under normal conditions, one mole of glucose will undergo glycolysis and will
end up with two molecules of pyruvate, ATP, and NADH. In the mitochondria, pyruvate will be
utilized in Krebs cycle generating more NADH, the oxidative phosphorylation electron donor,
generating 18-folds of ATP than in glycolysis.
Normally, most mammalian cells in culture depend on glucose and glutamine as the main
supply for most of the carbon, nitrogen, and free energy. Due to this fact, cells tend to alter the
glucose utilization of differentiated cell to meet the cell proliferation needs. For example,
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glucose will be converted to precursors such as Acetyl-CoA for fatty acid, non-essential amino
acids, and ribose for nucleotides.
2.2.2 Warburg effect and cancer cell metabolic symbiosis
In the 1920s, Otto Warburg reported that the tumor ascites had a high glucose
consumption and high lactate production under normal oxygen levels. This observation named as
the Warburg effect or aerobic glycolysis and considered a landmark of aggressive tumors.12, 13
The phenomena appeared to be associated with an increase in the glycolysis been supported by
molecular and functional data.14 Microarray data collected from different studies have shown
consistently an upregulation in genes related to glucose transportation and glycolysis in a wide
range of tumors.15-17 Glucose transporters have been reported by several studies to be
overexpressed in breast cancer, hepatocarcinomas, lymphoblastic and others.18-20
The metabolic reprogramming changes the metabolic activity by enhancing glycolysis
and restricting the Krebs cycle to lower the oxygen availability. Several regulatory pathways
contribute to the metabolic reprogramming of tumor cells include MYC, HIF-1α, and
PI3K/AKT/mTOR.
One of the main regulatory mechanism in aerobic glycolysis is by activating hypoxiainducible factor (HIF-1). The activation of HIF-1 alters the expression of 450 genes involved in
glycolysis, lactate production and lactate proton excretion, iron metabolism, angiogenesis, and
metastasis. Also, the genes involved in the upregulation of glycolytic enzymes different than
found in normal cells, such as glucose transporter (GLUT1, GLUT3), glycolytic enzymes (HKI,
HKII, PFK-1, ALDO-A, ALDO-C, PGK1, ENO-α, PK-M2, PFKFB-3), and enzymes related to
the production of lactate and lactate/ proton excretion (LDH-A, MCT4).21, 22 Hypoxia also
upregulates the production of two pyruvate dehydrogenase kinases (PDK1 and PDK2) carrying
the phosphorylation and the inactivation of three isoforms of pyruvate dehydrogenase (PDHA1,
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PDHA2, and PDHB) that convert pyruvate to acetyl-coA.23-26 Regulators like HIF-1 and Akt
may play an important role in acidosis. HIF-1 also enhance the expression of intracellular pH
(pHi) regulatory systems. These include monocarboxylate transports (MCTs), Na+/H+
exchangers (NHEs), proton pumps (V-ATPase), and membrane-associated and cytosolic
carbonic anhydrases (Cas). 27 These systems are important to maintain intracellular pH for cell
survival.
Tumor cells consume more glucose to secrete massive amount of lactate to toxify healthy
cells. However, cancer cells developed a survival mechanism to adapt to acidosis (toxic
environment). In addition, CO2 is another source of acidic extracellular pH (pHe). In the tumor
microenvironment, carbonic anhydrase (CA) hydrate CO2 producing bicarbonate (HCO-3) and
H+.28 Hypoxia and acidosis are usually associated, however, acidosis can be observed in
normoxic conditions because of the Warburg effect (Figure 2.2).
Moreover, studies showed developing hypoxia and acidosis in the microenvironment of
premalignant epithelial cells. The partial pressure (pO2) inside the tumor is relatively lower than
the surrounding healthy tissue. Hypoxia and acidosis create a selective environment in which
cells having metabolic adaptation by uncoupling glycolysis from the respiratory chain and using
glycolysis as the main source of ATP production.29
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Figure 2.2: Schematic drawing of cancer cell metabolism (Warburg effect).

In tumor cell populations the oxygen level varies generating well-oxygenated regions
(aerobic) and poor oxygenated (hypoxic) regions. Some studies revealed the fact that tumor cell
can change from hypoxic to normoxic conditions and vice versa in a very short period of time
and this can be called “metabolic symbiosis”.30-32 In the hypoxic conditions, cancer cells
increase the expression of GLUT-1, which is activated by HIF-1. Increasing the glucose flux, in
turn, increases the lactate production that needed to be secreted to prevent intracellular
acidification thought the monocarboxylate 4 system (MCT4), a lactate transporter coupled to H+.
On the contrary, cancer cells growing under normal oxygen level will take lactate instead of
glucose supporting the metabolic symbiont concept. In aerobic cancer cells, MCT-1 transport
lactate into the cell to be converted to pyruvate via lactate dehydrogenase B (LDHB). Krebs
cycle and its products will be oxidized through the Krebs cycle (OXPHOS pathway) for energy
10

production. Inhibiting MTC-1 will make aerobic cancer cells to consume more glucose than
lactate, breaking the metabolism symbiosis, leading the apoptosis of anaerobic tumor cells due to
glucose deprivation. MCT1 expression found to be exclusively in aerobic regions of human
tumor tissue from the head, neck, breast, and colon cancer. The result came along with the
expression of LDHB allowing the lactate utilization as a source of energy.29 The phenomena
were observed in murine mice model in which hypoxic tumor death was induced due to the
inhibition of MCT1 as a treatment from lung cancer. 29 This observation is critical to treat
patients, because blocking MCT1 in cancer cells allows chemotherapy and radiation treatment to
be more effective, especially in reaching the hypoxic zone within the tumor region. 33
To conclude, acidosis promote selective checkpoints of both cell cycle and apoptotic
mechanism.34 After several cell generation, acidosis select the most resistance phenotype for
higher invasion and metastasis.35 Acidosis will also facilitate the extracellular matrix degradation
to increase the cancer invasiveness leading to cancer spread (metastasis) through the circulatory
system and ultimately patient death.35 Therefore, diagnosis and treatment are critical to be done
before reaching the late stages to overcome bad prognosis.
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Chapter 3. Impedance Cell Biosensing Based on Nanomaterial

3.1 Cell Biosensing Using Impedance
Electrochemical Impedance Spectroscopy (EIS) is a well-established and widely used
technique in the biosensor’s development. EIS is highly a sensitive technology that uses
alternative current (AC) for detecting electrochemical phenomena over a wide range of
frequencies. This can be used as an electrochemical detection tool that is well known to be
simple, free label, real-time, and at low-cost.36, 37 Since the 1920s many research studies have
concluded that malignant breast tumors have a significantly different electrical impedance or
electro potential values compared to those of normal tissues and benign lesions, and such
properties are used to distinguish different tissues based on distinct electrophysiology
characterization of a particular tissue in the frequency domain.3, 38 Among all conducted studies,
the main focus is on studying pathological tissues. 39, 40 The EIS approach offers new cancer
detection technique of a variety of cancers in the liver41, skin42, and breast42, and the topic has
been discussed extensively in the literature reviews.36, 43-45
In 1984, Pethig 46 attempted to review the dielectric properties of tissues and
biomolecules. The review included various research studies which have, at a molecular level,
tried to analyze the dielectric properties characteristics of malignant breast tissues that may be
different in between normal and malignant breast tissue’s properties. Some of the characteristics
stated include higher water content and sodium concentration of cancerous cells, different
electrochemical properties of their cell membranes, and reduced membrane potentials. Normal
epithelial cells are electrically polarized by an ionic gradient across the cell membrane, and the
charge gradient between the apical and basolateral cell membrane is known as trans- epithelial
electro-potential.47,48 Na+/K+ ATPase pump maintains the electrical gradient across the

12

membrane. This electrical gradient difference creates a trans-epithelial potential difference of 30
mV (Fig.3.1).

CL- Na+ K+

Outside cell

Inside cell

Sodium Ions
Potassium Ions

Figure 3.1: Illustration of electrical gradient across the cell membrane.

When epithelial cells divide, the charge is dissipated, creating an electrical
depolarization. Therefore, the development of breast cancer will cause the cells to divide even
faster resulting in generating pockets of relative depolarization. Further, when the tumor
becomes invasive, it starts to destroy the ductal structure, thus increasing the permeability of
ions. This differential in electrical potential can be detected at the skin surface and can be used as
a diagnostic tool. Other studies 49-52 have used the membrane permeability, cellular water, salt
content, packing density, and cell orientation within the malignant tissue to identify cancer
lesions. In addition, any studies so far have confirmed that the impedance test can be used as a
tissue differentiation tool using specified frequency range.
Similarly, at the cellular level, electrical properties of the cell may vary depending on
biochemical changes caused by the disease.53 Electrical Cell-substrate Impedance Sensing
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(ECIS) was first introduced as a noninvasive method by Giaever and Keese to study the
properties of cell attachment.54 The cell contains an intracellular medium surrounded by a
semipermeable membrane, which separates the extracellular from the intracellular ionic
solutions, and both are resistive in nature. The cell membrane as we discussed earlier is made
from a lipid bilayer, proteins, and some polysaccharides. The membrane exhibits capacitive
properties due to the presence of the potential difference. The impedance of cell membrane
capacitance changes corresponding to the frequency. At low frequency, the cell membrane act as
an insulator preventing the current to flow through the membrane, and lead to have a higher
impedance level, i.e. highly resistive. When the frequency tends to be higher, the cell membrane
act as a capacitor and start to conduct and allow the current to go through the membrane
resulting in a lower impedance level.55
Since it is clear that the frequency can distinguish tissues pathological stages, scientists,
when plotting relative permittivity against the frequency, observed three distinct regions called
alpha (f <1000 Hz), beta (1000 Hz < f < 100 MHz) and gamma (f > 1 GHz) regions. 53, 56, 57 Blad
et al. 40 reported that alpha and beta regions are the best to detect cancerous cell electrical
properties that are different from normal cells.
Further, such biochemical changes can be detected through electrical impedance (EI)
sensing of cell-substrate interaction.58, 59 A cell suspension analysis conducted by Han et al.60
using a sophisticated chamber showed that significant differences occur in the phase angle and
magnitude of corresponding impedance over the frequency range of 100 Hz to 3 MHz in nontumorigenic MCF10A, MCF7 (non-invasive cancer cell line), MDA-MB231 and MDA-MB435
(invasive cancer cell line). Also, the membrane capacitance and resistance differences were
reported among those cell lines. Yang et al.61 conducted a real-time impedance-based
measurements of cellular activities using RT-CES system to distinguish OSCC cell line and the
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non-cancerous epithelial esophageal Het-1A cell line. Qiao et al.62 reported differences in the
impedance measurements in both suspension of MDA-MB231 and MCF10A breast cells using a
platinum needle as an electrode. Nwankire et al.63 created a centrifugal microfluidic system by
using a platform on a five-layered disc attached to a gold electrode functionalized with antiEpCAM to quantify ovarian cancer cells (SKOV3) extracted from a blood sample using EIS.
Thus, such studies have shown that impedance spectroscopy (EIS) is a powerful technique for
distinguishing cancerous cell electrical properties from normal cell electrical properties.
Furthermore, electric cell-substrate impedance (ECIS) has been used to reflect various
cells properties and behavior including attachment 64 and spreading65-67, motility68-70, and
proliferation.71 This approach can be also used to monitor cell response to drug treatment and
cytotoxicity assessment in real-time.72-74 Impedance- cell-based biosensors is further applied to
identify active molecular targets involved in various diseases.72 It is also involved in detecting
the drug toxicity and efficacy at a cellular level with nanoscale resolution.75
Kuo et al. studied the invasive properties of human breast cancer cells (MDA-MB 435)
into human umbilical vein endothelial cells (HUVEC) 76. MDA-MB 435 cells were treated with
transforming growth factor (TGF)-ß and added to HUVEC monolayer. In one hour, MDA-MB
435 invaded HUVEC resulting in decreasing the resistivity after 4 hours. The study also
demonstrated the cellular role of (TGF)-ß in activating mambrane type 1-matrix
metalloprotenase (MT1- MMP), which mediates the cleavage of CD44 to the soluble form.
CD44, in turn, plays an important role in cancer cell migration.
Recently, Stanica et al. used ECIS to evaluate hypoxia-induced bioeffect including pH on
the tumor microenviroment using a multiplexing module (8 channels) on human colon cancer
HT-29 cell line. 77 The study revealed a dynamic change of cellular responses during hypoxic
condition and in response to acetazolamide (AZA), a carbonic anhydrase inhibitor.28
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In conclusion, biosensors that utilize the electrochemical impedance technique present a
unique technology with a great potential to meet the rapid, real-time need for breast cancer
detection. It is important to point out that all metal electrodes in these studies are used without
any further surface modification, which can improve the detection sensitivity. Surface
modifications using different materials is a new direction that our group is being introduced in
this study.
3.2 Nanostructured Biomaterials and Biosensors
3.2.1 Development of nanostructured biomaterials
Nanomaterials can be referred as nanostructured materials, which have a size between 1
and 100 nm. These nanomaterials offer new properties compared to their bulk compartments and
are being used for developing new applications and devices to improve our daily life. In recent
years, a wide range of nanomaterials have been developed such as nanowires (NW), nanotubes
(NT), nano roads (NR), nanoparticles (NP), nanoflowers (NF), nanoshell (NS), nanocages (NC).
These nanostructured materials have established a new field called “Nanotechnology”.
Nanotechnology is defined as the field that studies materials to be synthesized, controlled, and
manipulated in nanometer size range. It is a rapidly growing field aiming to develop
multifunctional systems targeting, diagnosing, and treating devastating diseases such as cancer.
Nano-sized objects are carrying novel properties and functions that open the doors for creative
biomaterials to be used in biomedical applications. For example, medicinal and structural
chemists have been creating and manipulating nanometer- and sub-nanometer-sized components
of drugs for decades and will continue to do so into the foreseeable future. A “Nano bullet for
Tumors” is a good example of how research from diverse sources can utilize nanoparticles to

16

target cancer cells.78 The field showed promising developmental stages to design and create new
nanomaterials and technology to achieve the desired goal.

3.2.2 Nanofibrous bioscaffolds as extracellular matrix analogues
The extra cellular matrix (ECM) is a mesh network composed of both mechanical and
functional proteins, being unique tissue-specific assembled architecture. It provides both a
mechanical and functional substrate for cell signaling. The dynamic signaling of ECM is a key
role in tissue development and homeostasis.79 The synthetic nanofibrous scaffolds are designed
to provide a supportive framework for cell proliferation and survival, mimicking the ECM.80, 81
The ideal scaffold would promote cell attachment, proliferation, and differentiation. Earlier
studies showed the vital role for self-assembled peptide nanofibrous bio-scaffold to connect the
natural ECM and promote cell regeneration corresponding to a lesion.82, 83 To date, fabrication
of nanofibrous bioscaffolds can be achieved through mainly four techniques: electro-chemical
dip-in lithography, mechanical stretching 84, template-directed electrochemical synthesis, and
electrospinning.4, 85-87 The most well-known technique to produce nanofibers is called
electrospinning.85, 88 This method uses a microfabricated scanned tip, which is dipped in a
polymer solution to get a droplet as a source of material. Applying a sufficiently high voltage to
the tip generates a Tylor cone and a polymer will be extracted. Moving the tip, acting as a
counter-electrode, allows the nanofibers deposition on a substrate surface structure for
fabrication. Beside fabrication, electrospinning can also produce oriented polymeric selfassembled nanofibers.89-91 The diameter of the nanofibers can be controlled using various
methods.92-94 Furthermore, nanofibrous bioscaffolds can be modified and functionalized with
bioactive molecules to mimic the architecture of the extracellular matrix and promote cell
outgrowth. The designed structure, composition, morphology will ultimately impact the cell
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adhesion, proliferation, spreading, migration, differentiation corresponding to biochemical
signals.95, 96 Several studies discussed the mechanical strength and evaluation through theoretical
modeling of such nanofibrous assemblies and the challenges upon developing/forwarding the
technology toward the clinical settings.79 The fibrous alignment also showed significant results
in enhancing mouse embryonic stem cells (ESCs) differentiation into neural cells and further
outgrowth compared to the random nanofibrous alignment.97 A better understanding of the
synthetic scaffold materials in supporting different injury sites will improve their usage and
ultimately their clinical outcomes.
It is well known that human cells generate biological electrical field through voltage
gradient of 10-90 mv across the cell’s membrane. This gradient initiate cell signaling, which
alters cell proliferation and differentiation. This phenomenon inspired researches to develop
electroactive polymers to generate electrical stimulation for repairing injured tissues. Up to date,
a few studies showed a promising electroconductivity capability of the biocompatible scaffold.
Researchers have demonstrated the ability of these polymers to trigger cell proliferation and
differentiation corresponding to material’s electrical conduction.91, 98 Common electroconductive
polymers include polyacetylene (PE), polyaniline (PANI), polypyrrole (PPy), polythiophene
(PT) , poly(para-phenylene vinylene) (PPV), and Poly(3,4-ethylene dioxythiophene) (PEDOT)
.99 Piezoelectric polymers include Polyhydroxybutyrate (PHB), Polyvinylidene fluoride (PVDF),
and Poly(L-lactic acid) (PLLA), as well as polyelectrolyte gels. Bangar et al. used
dielectrophoretically aligned Polypyrrole (PPy) nanowires across a pair of gold electrode,
separated by 3 µm gap, for detecting cancer antigen 125 (CA 125) by corresponding antibody. 100
The immunosensor showed good sensitivity in low concertation (1 U/mL) as well as in higher
concentration (1000 U/mL). Although Ppy showed high sensitivity, it would be critical to know
the chemical stability of the polymer after several uses.
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Electroconductive polymers are also used to trigger neural, muscular, skeletal, and
cartilage cells differentiation and proliferation.91 However, the valid range of electrical
stimulation is not well defined. Therefore, more fundamental in vitro and in vivo studies are
highly needed to determine how different tissues respond to electrical stimulation. Another
challenge is how to promote a multi-tissue regeneration using such synthetic electroactive
scaffold in vivo with large animal models. Further studies should focus on investigating the
combination of both chemical recognition and conductive material, through ion-exchange or
electron transfer, which can be further applied in real-time for cell electrochemical sensing.99
3.3 TiO2-Based Nanostructured Bioceramics
3.3.1 Syntheses of TiO2 –based nanostructures
TiO2-nanostructured material has been synthesized through several methods: template
synthesis101, nano-seeding102, nanocoating103, electrospinning104, and hydrothermal synthesis5, 105
(Fig. 3.2). The template synthesis includes sol-gel template, sol-gel coating, polymer mold,
direct deposition, and super-molecular assembled process, in which a well-controlled length and
diameter TiO2 nanowire is aligned on a substrate.106-108 The electrochemical nano-seeding
include direct anodization of Ti foil in an H2O-HF electrolyte at room temperature or seeding Ti
substrate with the TiO2 nanoparticle.109, 110 The nanocoating synthesis Ti substrate is performed
by the Galvano dynamic anodizations.111 Alkaline hydrothermal synthesis was reported by Dong
et al, where Ti metal oxidation (corrosion) occur in a large-scale solution fabrication (NaOH or
KOH) at relatively low temperature. The nanowire root inside the Ti substrate was attached
firmly by an unusual downward growth, while the nanowire tip grows upward to self-assemble
to form the scaffold.112 The scaffold, reported by Dong et al, is composed of macropores of 2-10
µm in diameter promoting cell adhesion and proliferation, controlled drug release, photocatalytic
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sterilization, and electrochemical detection, which was an ideal multifunctional Titanium-based
implant.5

Fig. 3.2: Schematic for common synthesis methods of nanostructured TiO2.

3.3.2 Commonly seen nanostructures and dimensions of TiO2- based bioceramics
Many studies showed that titanate can be formed in different shapes and dimensions.
Fig.3.3 shows a summary of different TiO2 nanostructure morphology and dimensions: zerodimension, one-dimension, two-dimension, and three dimensions. Nanoparticles considered an
example of zero-dimension. Nanorods, fibers, tube, and belts are examples of one-dimension.
Nanoplates and sheets are a two-dimension structure. Due to the flexibility and diversity of
titanate structure, it considered as an excellent platform to incorporate other materials such as
metal oxides or transition metals113, 114, noble metals115, 116, and carbon-based material117, 118. The
surface properties of these composite are entirely different from the bulk material, due to the
quantum size effect.119
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Fig. 3.3: Schematic diagram of TiO2 of different dimensional structure.

3.3.3 Properties and applications of TiO2–based nanobioceramics
Alkali TiO2 is the most common form of TiO2 with the formula A2TinO2n+1 (A= Li, K,
Na). They are characterized by a large surface area with unique layers and tunnel crystalline
structures.120-122 It has been used for a long time as a white pigment in paint. After the discovery
of its photolytic activity on water under the UV light in the late 1970s 123, the field of TiO2based nanomaterial was established.124 The TiO2 structure known as “Zwitterionic”, meaning
that it consists of multilayers with negative charges and positive charge interlayers while
maintaining a zero-net charge for the overall structure (Fig.3.4).
The titanate has (TiO6) octahedron as the main building block.125-127 The edge shared (TiO6)
structure will for a negatively charged nanolayer structure. The cations (e.g. Na+) will fill the
adjacent layered spaces. The distance between the layers will depend on the type of cation (size)
and the hydration degree of the cation, which results in the flexibility characteristics of the long
nanofiber. Sodium titanate (Na4O4Ti) has been used in various fields including environmental,
medical, food, cosmetics, space, and energy (Fig.3.5).
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Figure 3.4: Illustration of layered TiO2 crystal structure
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Figure 3.5: Schematic diagram of TiO2 applications.

The ability of TiO2- based material to merge into various field came from its unique
chemical and physical properties. These properties include low toxicity, biocompatibility,
thermal/chemical/photochemical stability, optical transparency, and large surface area.
Moreover, the layered titanate nanomaterial is capable of cation intercalation. Meaning that the
material allows the process of ion exchange, which has been studied using alkali metals75 cations
and transition-metal-ions76. The interlayered distance remained the same after intercalating with
alkali metal cations (Na, K, Li, Rb, Cs) in aqueous solution.75 Magnetic and optical properties
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can be further tuned using different transition-metal cations (Ag+, Cu2+, Co2+, Ni2+, Zn2+, Cd2+)
by stirring the material in different transition-metal solutions. 76 Based on this, titanites could be
potentially a good candidate as an electrode material for a number of reasons including (i) easy
charge diffusion in to a short distance to reach inter-layer position, (ii) alkali ions in between the
titanate layers can be exchanged with other cations as described earlier, and (iii) cyclic stability
can be boosted by the intercalation process of ions to modify the layered structure and enhance
detection sensitivity.
3.4 Biosensors Based on Nanowires
A biosensor is an analytic device used for biological sample analysis. Its main role is to
convert response, either chemical, biological, or biochemical, into an electrical signal
proportional to the analyte concentration in the reaction.128, 129 Biosensor application are for
pollutants, pathogenic microorganism, disease-causing biomarkers detection, or drug monitoring.
A typical biosensor system (Fig 3.6) is composed of the following:
•

Analyte: The molecule or the complex compound being detected in the sample. For
example, glucose is a simple molecule to be detected in glucose sensor form body fluids
(blood, urine, saliva). Hormones, cells, and pathogenic bacteria are also examples of
complexed subjects that can be detected by biosensors.

•

Recognizer: The part of biosensor that recognizes the interested analyte is also known as
bioreceptor. Enzymes and antibodies are a good example for bioreceptors. Upon the
interaction, a signal will be generated (inform of pH change, heat, light, charge or mass
transfer), and this is known as bio-recognition.
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Figure 3.6: Schematic illustration of a typical biosensor.

•

Transducer: Is the equipment that converts the signal from one form to another. In
biosensor, the signal can be converted from chemical to electrical or optical signal and
this is known as signalization. The amount of signal is proportional to the amount of
analyte in the sample

•

Converter: It consists of complex electronic circuitry and responsible for converting the
signals from analogs to digital form preparing it to be quantified.

•

Display: The part responsible for generating the results in an understandable and userfriendly manner. The results will be shown as numbers or graphs on a computer screen.

The following criteria must be implemented to construct a successful biosensor:130
•

Selectivity: it is reflected by the ability of the biosensor to detect a specific analyte in a
sample containing a mixture of other analytes or contaminants. Antibody-antigen
interaction is the best example of high selectivity. Usually, the antibody will be
immobilized on the surface of the transducer and the antigen will be present in the
sample and will interact with its specific antibody to generate the signal.
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•

Sensitivity: It is also known as the limit of detection (LOD), which is the minimum
amount of analyte can be detected by the system. In case of simple molecule analyses,
the detection range should reach as low as ng/mL or fg/mL. For example, prostatespecific antigen (PSA) will be present at low concentration in the blood (4pg/mL) as a
characteristic of prostate cancer. Therefore, sensitivity is crucial for an effective
biosensor.

•

Stability (shelf-life): Is the degree of consistency and the ability to avoid any destruction
in and around the biosensor. Any disturbance can cause an error and a shift in the signal
being measured. The interaction between the analyte and the bioreceptor should be a
strong electrostatic bounding or a covalent linkage to ensure the stability of the system.

•

Reproducibility: The ability of the biosensor to generate similar up to identical responses
in repeated measurements. This reflects the high reliability and robustness to the
response generated from the biosensor. It is an important characteristic of a precise
transducer and electronic system in the biosensor.

•

Linearity: It reflects the accuracy of analyte measurement. For example, measuring the
different concentration of analyte reflects a linear relationship, which can be
mathematically represented by O= sc, Where O is the output signal, c is the
concentration of an analyte, and s is the sensitivity of the biosensor. The concentration
range of analyte that generate a linear biosensor response is called linear range. Linearity
is also associated with the resolution of the biosensor, which is the smallest change in
analyte concentration to generates a response in the biosensor.

•

User-friendly and mass-producibility: simple, low-cost, small, minimal sample size and
pre-treatment, rapid measurement, and real-time analysis.
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Recently, researchers aimed to reduce the size of biosensors for many reasons. For
instance, reducing the biosensor size to the micro- or nano-scale showed advantages such as
increase the surface to volume ratio, improve the sensitivity and efficiency of detection, reduce
the signal-to-noise ratio, lower sample size, and lowering the cost.131
Interestingly, the nanoscale electrochemical systems have lower double layer capacitor
due to the decrease in the electrode area. Thus, the system has low solution resistance Rs and
double layer capacitance Cdl allowing ultra-fast electron transfer kinetics for detecting short-life
species in short time, which can reach up to the nanosecond scale.130 It is also applicable to keep
both Rs and Cdl constant to perform the detection without the need of supporting electrolyte.132
In terms of nanomaterials, the discovery of graphene sheets and metal oxides in different
shapes are being reported in the literature, especially in electrode fabrication. Biosensors with
further nanoscale fabrication can lower the detection limit more than previously reported and
potentially improve future single-molecule detection.
3.4.1 Silicon nanowires for biosensing⸻the state-of-art at present
Cancer biomarkers are used to predict the tumor prognosis. Since they are present in the
tissue or blood in extremely low concentration, a highly sensitive detection method is needed.
Several studies have used silicon nanowires as a biosensor for medical diagnosis. 133
For example, prostate-specific antigen (PSA) normally excreted by prostate cells in very low
concentration, while higher concentration is related to prostate cancer existence. The field of
nano-sensing started with using silicon nanowires (SiNW), which was first reported by Liber’s
group. n-type and p-type silicon nanowires were functionalized by monoclonal antibodies (mAb) for three cancer markers: free protein-specific antigen (f-PSA), carcinoembryonic antigen
(CEA), and mucin-1 showing high selectivity and sensitivity.134 Further, Kim et al. developed an
ultrasensitive (n-type) SiNW- field effect transistor (FET) biosensor fabricated by a top-down
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approach for detecting PSA. The detection sensitivity also increases to reach below fg/mL by
decreasing the nanowire dimension because the n-channel with low density can be easily
depleted by negatively charged molecules.135
MicroRNAs are another example of biomarkers, consisting of 20-24 nucleotides-long
noncoding RNA molecules, involved in gene post-transcriptional regulations and affecting both
the stability and translation of mRNAs in eukaryotic species. Existing methods are depending on
indirect methods through hyperdilation to a complementary probe molecule or a labeled target
miRNA. Thus, it is important to develop a direct detection method being simple with high
selectivity and sensitivity. Zhang et al. 136 developed a free-label direct detection to miRNA (let7b) using immobilized peptide nucleic acid (PNAs) on the surface of SiNW. PNA is neutral and
doesn’t have anionic phosphate backbone. This results in increasing the melting temperature and
enhancing the RNA-PNA hybridization efficiency. Further, the detection of let-7b showed an
increase in the resistivity corresponding to the increase in concentration from 1fM to 1nM. The
essay was further tested by extracting let-7b from Hela-cells. The let-7b was diluted with buffer
solution and detectable concentration was 2.15 ± 0.25 × 107 copies/ µg RNA being acceptable
when compared with previously published work using array-based Klenow enzyme (RAKE)
assay. 137
Recently, only two groups applied SiNW for cell sensing application. Abdolahad et al.138
fabricated a circular shaped sensing electrode with SiNW using thermal oxidation and being
doped with c-phosphorus. The free label sensing electrode was used against another SiNW
counter electrode forming a bioelectronic device to detect invasive colon cancer cells (SW48) in
a mixed sample with another benign colon cancer cell line (HT29) in different ratios. Results
showed different membrane dielectric properties reflecting the pathological condition of the cell
before and after metastasis. Shashaani et al.139 used a similar electrodes configuration to test
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Mebendazole (MBZ, 2nM) drug effect on MCF7 by releasing Cytochrome C to its cytoplasm,
which ultimetly changed the cells electrical activity (anodic/cathodic peaks). The changes were
detected using cyclic voltammertry (CV) and differential pulse voltammograms (DPV).
Alikhani et al.140 investigated the relation between acidosis (decrease pH) and electrical
resistivity among breast cancer cells. The study reported that the most aggressive cell line
(MDA-MB468) recorded higher electrical resistivity in acidic medium (pH 6.5) compared to
moderate (MCF7) and sharp (MCF10) decrease in their resistance.140
Although silicon nanowires appear to be promising materials, they form a silicon dioxide
(SiO2) layer (silica) when being exposed to oxidizing agents (e.g. air or water). This can affect
electrical conductivity because SiO2 is an electrically insulating material and will ultimately
affect the semiconducting properties that silicon nanowires might have.141
3.4.2 Titanate nanowires for biosensing⸻the game changer
Various forms of TiO2 based materials such as nanotubes142, 143, nanoparticles144,
nanosheets145, sol-gel macromatrics146, and 3D microporous material147 have been used
extensively to develop biosensors for medical diagnosis.148
As mentioned earlier, the unique chemical and physical properties have attracted
researchers to use titanate in different applications in the life science and medicine. Recently,
titanate nanowire material has attracted attention to be used in bio-sensing technology. This is
due to their unique properties of being semiconducting with high sensitivity to detect even a
single molecule.4 Titanate based semiconductor nanowires can be grown on top of Titanium
metal and in turn it can be used as an electrode to sense cancer cells. These titanate nanowires
can have their band gap varied between 1.8 and 4.1 eV, making it unique from other nanowires
in giving the best sensitivity ranges. In addition, the titanate nanowires are easy to fabricate, hold
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high biocompatibility and chemical stability.5 These properties make TiO2 nanowires an ideal
material for biosensing applications.
So far, only a few studies have shown a promising use of TiO2 nanowires as biosensors.
Wang and his coworkers have implemented TiO2 nanowire (TNW) microelectrode for detecting
Listeria monocytogenes.149 A specific monoclonal antibody for Listeria monocytogenes was
covalently attached on the TNW surface and placed in between two gold microelectrodes
blocked with 2-methyl-2-propanethiol (SH-(CH2)3-CH3). The detection limit could detect as low
as 102 CFU/mL of Listeria. Luo et al. demonstrated that TiO2 nanowires can be conjugated with
cytochrome c and applied to detect H2O2 being secreted from liver cancer cells (Hep G2).150
H2O2 is considered a metabolic biomarker for cancer cell characterization. The study showed
linear amperometric responses for H2O2 over a broad range and low detection limit (2-100 mM).
Recently, another group used TNW to immobilize Horseradish peroxidase (HRP) as a H2O2
sensor.151 The detection limit reported is lower than the previous study to reach 1.2 µM/mL with
30-days stability, retaining 91% of its activity and showing fast and sensitive response compared
with other biosensors made from different nanomaterials.
To conclude, the TiO2-nanowire is a promising nanomaterial that showed promising
biosensor capabilities. Few studies were done using TNW materials. Up this point, the usage of
TiO2-nanowires to characterize and study the cell behavior under different pathological stages,
stimulators, or pharmaceutical effects have not been reported. Thus, the purpose of this study is
to introduce the TiO2-nanowires ability in recognizing the electrochemical properties of cancer
cells and apply them to help in developing a prognostic tool for future diagnostic technology.
This new method also can be potentially used in various important applications in cancer
screening and monitoring, which are doable in vitro at ultra-low-cost and in real-time.
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Chapter 4. Major Methods for The Characterization

4.1 Power X-Ray Diffraction (PXRD)
X-ray diffraction (XRD) is long-used as a reliable method for characterizing a crystal
phase. It tells the atomic and the molecular structures in a three-dimension (3D) crystal lattice. The
XRD instrument consists of three main parts: X-ray tube, substrate, and the detector. When the
monochromic X-ray striking on the sample, the scattering X-rays from crystallized atoms can
interfere and diffract into a unique XRD pattern, as characteristics of the crystal lattice, that can
be detected by the XRD detector. The PXRD is commonly used to identify the crystal phase,
orientation, size and perfection of nanomaterials, based on the Bragg’s law:
2dsin𝜃 = 𝑛𝜆, (1)
where the (d) is the spacing between two parallel and identical lattice-planes, (𝜃) is the
XRD angle between the incident beam and the atomic plan in the 0-180° arrangement, (n) is an
integer (order of the XRD), and (λ) is the wavelength of the incident X-Ray beam. Since the angle
(𝜃) collected form diffracted beam and the wavelength are known, the lattice parameter (d) can be
calculated from Bragg’s law, a. s explained in detail in the Fig. 4.1. Standards in Joint Committee
on Power Diffraction Standers (JCPDS) or International Center for Diffraction Data (ICDF) can
be used to identify the crystal structure of a new nanomaterial, which is a common practice in the
nanomaterial’s chemistry.
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Figure 4.1: Bragg’s Law illustration.

4.2 Scanning Electron Microscopy (SEM)
Compared to regular optical microscope, the SEM provides a higher magnification (10,000
times more), higher resolution, and much clearer three-dimensional (3D) image with a much
greater focal depth. Therefore, SEM is used commonly to characterize the topography and the
morphology of the material of interest. The topography reflects the relationship between material’s
surface feature and the properties of that material. On the other hand, the morphology reflects the
nanomaterial’s shape, size and spatial organization that are all crucial to widely vary the
nanomaterial’s properties and applications.
An SEM is basically structured as shown in the Fig 4.2. The electron gun generates a
focused beam of electrons from, commonly, a tungsten filament with a sharp loop-tip that emits a
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narrow stream of electrons upon being heated by an electrical current. The anode (accelerator) is
located under the electron gun, using its negatively charged surface to repel negatively charged
electrons thus focusing and accelerating them. The magnetic lenses are to focus the electrons on
to the sample i.e. narrowing the beam of electrons to hit the sample.
In the SEM sample preparation, the sample surface is coated with gold usually in a plasma
sputtering coater under a vacuum form a mechanical pump. The surface gold coating provides an
electric grounding path to prevent the electron-accumulation (charging) problem thus-getting a
clear micrograph, on the SEM detector, of the sample surface topography.

Figure 4.2. Schematic representation of the basic SEM components.
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4.3 Electrochemical Impedance Spectroscopy (EIS)
Electrochemical Impedance Spectroscopy (EIS) is a well-established method widely used
in biosensing, using an alternative current (AC) to detect electrochemical impedance. The
impedance is defined as the ability of circuit to resist the flow of electrical current in a complex
system, for measuring over a wide range of AC frequencies the dielectical properties of a material.
EIS has been used in this work to develop a label free biosensor that hopefully can distinguish
multiple electrochemical changes occurring at the same time. For example, it may identify the
diffusion-limit of a passive film and the electron transfer rate of a reaction, the capacitive behavior
of the system, etc.
In the impedance sensing experiment, an AC voltage signal (V(ω), usually sinusoidal) is
applied as a frequency-dependent excitation. Then, a response (I(ω)) is measured (Fig. 4.3).43
Zw = Ew/Iw , Z w= Frequency-dependent impedance, SI unit ohm (Ω)
Ew = Frequency-dependent potential (voltage), mV
Iw = Frequency-dependent current, A
a)

b)
E

Figure 4.3. a) The phase shift between the voltage and current. b) The phase shift as an angle
between the real (ZRE) and imaginary (ZIM) parts of the complex impedance.
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Phase shift between voltage and current can be expressed by (Fig 4.3 (a)):
•

excitation as f(t)

Et = Eo sin (wt)
Where:
Et- potential at time t
E0- amplitude
w- radial frequency = 2𝜋𝑓
f - frequency

•

response signal

It = Io sin (wt + f)
Where:
It - response at time t
I0 - amplitude

f - phase
The real (ZRE) and imaginary (ZIM) parts of the complex impedance are called resistance and
reactance (Fig 4.3 (b)).
4.4 Randal’s Equivalent Circuit
The electrochemical cell can be modeled by electrical circuit elements that be determined
by EIS (Fig. 4.4), in which,
Resistor, Z = R (Ohms), 0° Phase Shift
Capacitor, Z = -j/wC (Farads), -90° Phase Shift
Inductor, Z = jwL (Henrys), 90° Phase Shift
j = √−1
w = 2pf , radians/s, f = frequency (Hz or cycles/s)
A real response is in-phase (0°) with the excitation. An imaginary response is ±90° out-of-phase.
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Warburg Impedance: It represents the resistance to mass transfer (diffusion control),
and typically exhibits a 45° phase shift. Equations of equivalent circuit:

Figure 4.4: The equivalent circuit, with the nanowire induction (L), nanowire resistance (R1),
cell membrane capacitance (C2), cell membrane resistance (R2), intracellular matrix capacitance
(C1), intracellular matrix resistance (RCT), and Warburg diffusion impedance (W01).
Table 4.1: Equivalent Circuitry Parameters.
Equivalent Circuitry Parameters
Determined Empirically in the
Work

Values

L

1x10-7

R1

50 (Ω)

R2

10 (Ω)

C1

1x10-6 (F)

C2

2x10-6 (F)

RCT

3 (Ω)

Sigma (𝜎)

0.0005

The overall impedance of the circuit in (Fig 4.4) is given by:
5

Z = j 𝜔 L +R1 +

34 6789
5

34:6789

5

+

(3<=:>?)(6785)
5

3<=:>?: 6785
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The Warburg impedance diffusion is described by
Zw =

B
C5/9

D

-

B C5/9

Where 𝜎 is related to the diffusion coefficient of species in the cell (see Bard)152
When separated in the real and imaginary components

Z w = R e + j Im
Re= 𝑅1+
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Where:
A= 1+ (𝜔 C2 R2)2
B= 1+

TR C9
B

C= 𝜔 C1 (RcT

+

B
C5/9

), 𝜔= 2𝜋𝑓 , 𝑓 = frequency of interrogating signal
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Part II
Chapter 5. Materials, Chemicals and Experimental

5.1 Materials and Chemicals
Titanium substrates (foil,0.25mm (0.01inc) thick, 99.99% metal base) was acquired
from the Alfa Aesar, USA. Sodium Hydroxide (NaOH) pellets from Avantor performance
martials, Sweden. Glucose was obtained from Sigma-Aldrich, Inc., USA.
Phosphate Buffer Saline (PBS) was prepared following the table:

Table 5.1: Regents for preparing PBS (pH7.40, 1L)
Chemical

Maas (g)

Sodium chloride (NaCl)

8g

Potassium Chloride (KCl)

0.2 g

Sodium phosphate dibasic Na2HPO4

1.44 g

Potassium phosphate dibasic KH2PO4

0.24 g

An 800 ml of deionized distilled (DDI) water was charged in an a one-liter polyethylene
bottle and stirred with a magnetic stirrer while adding the chemicals in the order (Table 5.1). The
pH was adjusted to 7.4 by titrating with a 1M HCl solution, the volume was adjusted to one litter,
and the bottle was stored in a refrigerator at 4℃.
Four cancer cell lines, MCF-10A, MCF7, MDA-MB 231, and HCT 116 (all from the
ATCC, USA) were obtained from Dr. Du’s and Dr. Shi’s labs (the first three) and Dr. Muldoon’s
lab (the HCT116) on campus through collaborations. The MCF 10A is a normal human epithelial
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cell line, MCF7 is a human non- invasive epithelial breast cancer cell line, MDA-MB231 is a
human invasive epithelial breast cancer cell line. The HCT 116 is a colon cancer cell line.

5.2 Experimental
5.2.1 TiO2- nanowire hydrothermal synthesis
A titanium sheet (from Alfa Aesar) of 1.5 cm ´ 2.0 cm in size was sonicated in 10 mL of acetone
in a vessel for 15 min at room temperature (25ºC), then taken out and rinsed with DDI water (Fig
5.1). Next, the Ti-sheet was placed in 10 mL of 1.0 (M) NaOH solution in a Teflon-lined vessel
(Parr Instruments, Figure 5.2) that was sealed and hydrothermally heated in an oven at 160-250
ºC for 4−8 hrs, then cooled in air outside of oven for 4− 24 hours. Thus-treated sample now,
surfaced fully with the titanate nanowires-entangled scaffolds, was rinsed with DDI water until the
surface reached pH » 7, and dried in air.5 Lastly, each sheet was scratched atop to expose metal
for connecting the electrode, and epoxy-glued on rest edges and back, leaving a small front area
sensing cells.

5.2.2 The nanowire characterization
5.2.2.1 X-ray Diffraction (XRD)
The phase purity and crystalline structure of the nanowires were characterized by X-ray
diffraction (XRD) using Rigaku Miniflex X-ray diffractometer with a Cu Kα (λ=1.5405Å)
radiation source, scanning from angle 20 to 70 (2θ) with a 0.02 ̊ step and a step time of 1.25 s.
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Titanium (1.5 cmx1cm)
Sonication: 10mL of acetone for 15 min
Rinse: Deionized water
Mix solution: 1M NaOH in 10mL DDI
HO
Sealing in Teflon liner/Autoclave Vessel
Anneal: 160-250ºC for 4-8 hrs
Cooling for 4 hrs
Wash: Deionized water until pH=7
Dry- glue with epoxy- heat at 80ᴼC for 3
hours
Figure 5.1: Schematic illustration for TiO2-Based nanowire hydrothermal synthesis process.

Figure 5.2: The autoclave chamber (left) and the Teflon liner (23mL) (right).
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5.2.2.2 Scanning electron microscope SEM
The morphology of the nanowire scaffolds was examined under a scanning electron
microscope (SEM, Tescan SEM VEGAII SBH) performed at 30kV. Both top and cross sections
of TiO2-based nanowire.

5.2.2.3. Point-of-Zero-Change (PZC) of H-Titanate nanowires
To estimate the PZC of the TiO2-nanowire, a range of different pH from 2 to 12 were
prepared by using 0.1 M of hydrochloric acid (HCL) and 0.1 M of sodium hydroxide (NaOH) in
the DDI water. The pH was checked by the pH meter. The aqueous solutions containing the sample
were rotating overnight at room tempreture. The rotating will allow the nanowire to be exposed to
the different pH solution. The clear solution will be used to measure the final pH using the pH
meter and the result of initial and final pH will be used to determine the Point-of-Zero-Change
(PZC).153

5.2.2.4 Impedance characterization of the nanowires
The platinum (Pt) was the counter electrode. The titanate scaffold sheet in a similar initial
impedance curve was used as background. The impedance was tested by means of a Gamry
Potentiostat (Reference 600, Gamry Instrument, USA), with the parameters of 5mV AC and
frequency range 0Hz-1MHz (Fig. 5.3).
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Figure 5.3: Schematic illustration for the set-up and corresponding equivalent circuitry.

5.2.3 Bioimpedance cell sensing on the titanate nanowires
5.2.3.1 Impedance test for breast cancer cell lines
This test was carried out to determine if the biosensor can distinguish the cancer cells
pathological malignance. The frequency was swept to determine range giving the a clear
impedance difference (separation) between the cancer and normal cell line. At least three
such biosensors having similar initial impedance curve were incubated in a 10ml (1´PBS)
solution containing one million (106) cells/ml for 35 minutes at room temperature (25℃),
with each of the three breast cells lines (MCF10A, MCF7, and MDA-MB 231) and one
colon cancer cell line (HCT116), respectively.
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5.2.3.2 Impedance test for breast cancer cell lines at various incubation frame
Cells where incubated in different time intervals (25, 35, and 45 minutes). The impedance
was recorded for the three cell lines (MCF10A, MCF7, and MDA-MB 231) to determine the
best incubation time to do the impedance test as described earlier. The parameters setup was by
changing the frequency starting from 30 kHz till 1MHz.

5.2.3.3 Impedance test for normal and breast cancer cell lines in mixed sample
This test aims to determine if the biosensor can detect the presence of abnormal cells within
the normal population and can distinguish the pathological stage of cancer cell. Both cancer cells
lines (MCF7 and MDA 231) where mixed with normal cell line (MCF10A) in different (cancer
cell: normal cell) ratios (1:100, 1:50, 1:25, 1: 10, 1:5). The parameters setup was by changing the
frequency starting from 30 kHz till 1MHz.

5.2.3.4 Impedance test for breast cancer cell lines at 37℃
This test was conducted to determine if the tempreture affect the different cell impedance.
The cancer cell lines and the biosensor (TiO2) where incubated for 35 minutes. Impedance test was
done as described previously under two different tempreture, 25 and 37℃. The parameters setup
was by changing the frequency starting from 30 kHz till 1MHz.

5.2.3.5 New impedance test for glucose effect on the breast cancer cell lines
This test was done to investigate the effect of glucose on the cancer cell behaviors and in
turn the impedance readings. The four cell-lines (MCF10A, MCF7, MDA-MB231, and HCT116)
were suspended in a 10mL 1´PBS containing 5.5 (mM) of glucose. The impedance test was done
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as described in the above. The parameters setup was by changing the frequency starting from 40
kHz till 1MHz.

5.2.3.6 New impedance test for Doxorubicin effect on the breast cancer cell lines.
This test was performed to investigate the effect of a well-known chemotherapy drug
Doxorubicin on two different cancer cell lines. MCF7 is known to be more resistive to DOX than
MDA-MB231.154 To investigate the cell impedance change due to the DOX, the two cell lines
were first cultured to reach 90% confluence and then the DOX (2𝜇M) was added over two timeintervals, 24 hours and 48 hours. The cells were then harvested using trypsin and counted using
the hemocytometer and trypan blue stain to control the cell number. The cells were then suspended
in 10mL of 1´ PBS with the TiO2-nanowires sensor for 35 minutes, and the impedance was tested
likewise from 40 kHz to 1MHz.
The second set of experiment was done as in the first step, with glucose (5.5 mM) in the
cell suspensions to investigate the cell impedance correspondence to glucose effect after being
treated with DOX. The biosensors were done after 35 minutes in the cell suspension, with the
impedance parameters same as described previously.

5.2.4 Microscopic visualization using Fluoresce staining
After the data collection, the three scaffolds were dyed with SYTO®24 GreenFluorescent Nucleic Acid stain (from Life Technology) with 490 absorptions and 515 emission
wavelengths to visualize the attached cells. After fluorescence images were taken by Olympus
BX41 microscope, cells were detached with trypsin and washed until no significant fluorescence
could be seen. The test confirms the attachment of cells to the TiO2- nanowire surface and
confirming that the change in nanowire resistivity is coming from cell attachment.
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5.2.5 Error analysis
All experiments were repeated three times using the same TiO2-nanwire scaffold. All cell
suspension contains the same cell number/ml. All data are expressed as mean ± standard
deviation for at least three repeats.
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Chapter 6. Results and Discussions
In Fig. 6.1, the intermediate sample (4hrs reaction) looks dark grey, and the final product
of the nanowire-covered surface seems grayish, both far from the Ti-metal that looks like the
stainless steel. This implies that even the Ti-metal and nanowire should show different PXRD
patterns.

Ti

Intermediate

TiO2

Figure 6.1: The physical morphology of titanate after the hydrothermal treatment.

6.1 Nanowire Characterization
6.1.1 Powered X-ray diffraction (PXRD)
The PXRD study was conducted to characterize the crystallinity and structure of the
nanowires grown directly on the Ti-metal surface. The Fig. 6.2 shows the PXRD pattern of a
typical sample with the nanowires grown in situ on the Ti-metal. Comparing with the data
reported by others including those from our same lab in literature 5, the five peaks at the 2-theta
values of 32, 34, 36, 38.5, 40 ,53, 70, and 78 belong to the Ti-metal under the nanowires, while
the rest peaks at the 2-theta values of 10, 24, 28, 48, 50 match the clay-like layered structure of
sodium titanate (Na2Ti3O4).
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Figure 6.2: PXRD pattern for titanate nanowire pattern of a typical sample with the titanate
nanowires on the Ti-metal after 24 hours of the hydrothermal treatment (see the discussion on
the time-study below).
6.1.2 Scanning electron microscope SEM
As schematically illustrated in the Fig. 6.3, the SEM micrographs illustrated the growth
and entanglement of the nanowires in the hydrothermal reaction on the Ti-metal. After the
hydrothermal treatment for 4, 8, and 12 hours, the nanowires grew long enough over time to start
to naturally entangle atop, self-assembling into the bioscaffolds with “bird-nest” like concaves (i.e.
cell-nest) on the sample surface, as depicted in the cross-section images in the Fig. 6.4. Further
prolonging the reaction time to 7, 18, and 24 hours, respectively resulted in slightly better
developed and organized cell-nests (Fig.6.5). On this basis, the samples from 8-hours of the
hydrothermal growth with enough well-developed “cell nests” were chosen to support the lowcost, quantitative, label-free, and real-time detections and differentiations of cancer cells for the
first time on a smart bioscaffold.

46

Tita

nium
Hydrothermal
reaction

TiO2
nanofiber

Titan
ium

1µm

Figure 6.3: A schematics for illustrating the change on the Ti-metal surface after the
hydrothermal reaction, as supported by the SEM micrograph.

4 hrs
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7µm
5µm
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18µm

10µm

Figure 6.4: The SEM study on the nanowires from the growths over the 4, 8, and 12 hours.
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20µm

a) Top microscopic view of bioscaffold
cages

b) Cross-sectional tilt SEM view

Nanofibers-nested cages

500 µm

10 µm

Figure 6.5: The SEM characterization of the bioscaffolds on the typical sample from 8-hour
hydrothermal synthesis. (a). The face-on view on the sample-top; (b). The tilt view.
6.1.3 Point-of-Zero-Change (PZC) on H(Na)-Titanate
To understand the surface cation exchange of titanate nanowire, a simple pH-titration was
conducted to estimate, on the nanowire surface, the point of zero charge (PZC) value from the
equilibrium between the H+ on the nanowire surface and that in the solution. In the plot of the
initial vs. final pH values (Fig. 6.6), the flat region’s pH is often regarded as the PZC.153
Accordingly, the nanowire’s surface ion-exchanged protons (H+) (i.e. Lewis acid) and
surface hydroxide (OH-) (i.e. Lewis base) groups can co-affect the average surface acidity/basicity
at the nanowire-water interface. This further suggests (i) the continuous H+↔Na+ ion-exchange
can make the nanowire surface to buffer between pH 4 (of the hydrogen titanate) and pH 10 (of
the sodium titanate),155 (ii) the capacity and kinetics of nano-buffering may reflect the
completeness of intercalation of the Na+ with the H+ on the titanate nanowire, (iii) the negative
framework made of (Ti3O7)-2 tend to be a multi-deck Lewis base host, as H+ is a strong but Na+
is a week Lewis-acid guest. This new insight of the surface dynamics in the solution surface
nanochemistry and “conjugated acid-base” nanochemistry supports that a controlled time (i.e.
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degree) of the DDI washing (i.e. H+ exchange) can convert the nests of as-made Na-titanate
nanowires to that of a H(Na)--titanate nanowire with a PZC at/around the pH 7 for doing the cellbiosensing.
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Figure 6.6: Point of zero charge (or isoelectric point) of the DDI-washed titanate nanowires
from the titration between pH 1 and pH 12.
6.1.4 Impedance characterization for the titanate nanowires-entangled cell-nests
A series of (1×) PBS solutions between pH 4 and pH 8 were used to quantify the effect of
pH on the impedance of the titanate nanowires-entangled cell-nest (Fig. 6.5). The result shows a
clear correlation between the impedance and solution pH, in which the impedance increases
generally with the pH. This correlation can be explained again with the Lewis acid/base theory.
In the aqueous solution, the hydroxyl group on the nanowire surface was deprotonated and
negatively charged when the pH ~ 7 (i.e. above the PZC point). On the contrary, the surface -OH
groups being protonated (gain H+) will be positively charged at the pH < PZC point.153 This is in
line with such a fact that an oxide in an aqueous solution above (or below) its PZC the surface
pH decreases (or increases) as the surface be deprotonated (or protonated). At equilibrium, no net
49

proton transfer thus no further change to the PZC point. Thus, the electrical impedance of the
nanowires (with the poor electrical conductivity) is commonly used to quantify such surfacePZC point shifting corresponding to the mass transfer of ions of any type in a confined area.
Equivalently, when the solution pH decreases, the nanowire surface is more protonated, gaining
more positive charges on the nanowire surface to facilitate a faster charge-transfer along the
nanowire surface and to reduce the impedance. This supports Fig. 6.7 and in turn how crucial the
water-washing step in controlling the nanowire surface PZC point.
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Figure 6.7: The impedance measurements of titanate surface corresponding to pH titration.
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Figure 6.8: Illustration of surface deprotonation and protonation corresponding to the aqueous
solution pH change.
6.2 Impedance Sensing of Live Cell on the TiO2-Nanowires.
Characterizing individual cancerous cells from the blood stream i.e. the circulating tumor
cells (CTC) tumors using a simple and quick impedance test is of importance to support both
qualitative and quantitative cancer pathology beyond the current practices using either staining or
optical imaging that are slow, labor-intensive and expensive. When cancer cells of the malignant
and benign subtypes look similar from one another using the staining and optical imaging.
However, the subtypes difference in metabolism should enable us to develop an alternative
diagnostic tool with negligible false-negative and false-positive problems, which has been
underexploited. Such new method should rely on the cancer cells’ metabolic wastes among
which the ionic spices can change our nanowire-bioscaffold surface’s charge-transfer pattern,
thus-affording the new cell-sensing method.
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6.2.1 Impedance test for breast cancer cell lines over the sensing time
Cells contain an intracellular medium surrounded by a semipermeable membrane, which
separates the extracellular from the intracellular ionic solutions using the cell membrane made
from a lipid bilayer, proteins, and some poly-saccharides. The membrane exhibits capacitive
properties due to the electrical potential difference between the membrane’s two sides, and the
impedance of cell membrane’s capacitance changes with the frequency. At low frequency, the
cell membrane is more like an insulator, resulting a higher impedance (i.e. highly resistivity) that
allows current in the extracellular medium. When the frequency is high, the cell membrane is
like a capacitor and starts to conduct charges and allow the current to go through the membrane,
thus-reducing the impedance signal.
In our experiment, more cells were attached onto the nesting nanowires over long time
after the bioscaffold-sensor was inserted in the PBS solution containing the cells. Different cells
upon attaching onto the nanowire-nest surface can instantly change the nanowires’ impedance
differently. After the attaching for about 35 minutes, normal breast cells (MCF10A) shift the
impedance by 40−50 ohms at the high frequency range (1MHz) (Fig. 6.9), while the benign
breast cancer cells (MCF7) shift that to about 60 ohms (Fig. 6.10), and the malignant breast
cancer cells (MAD 253) can do so by 80 ohms (Fig. 6.11). The Figs. 6-11 suggest that the net
surface charge for the three cell lines are different, therefore, they change the nanowires surface
charge differently, which can be better seen in thus-combined Fig. 6.12.
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Figure 6.9: Impedance vs Frequency for normal cells (MCF10A) in three-time frames (25,35,
and 45 minutes). The error bar reflects three repeats.
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Figure 6.10: Impedance vs Frequency for benign cancer cells (MCF7) in three-time duration
(25,35, and 45 minutes). The error bar reflects three repeats.
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Figure 6.11: Impedance vs Frequency for malignant breast cancer cells (MDA-MB231) in threetime durations (25,35, and 45 minutes). The error bar reflects the three repeats.
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Figure 6.12: Impedance vs Frequency for three breast cancer cells (MCF10A, MCF7, MDAMB231) in three-time duration (25,35, and 45 minutes).
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Dobrzynska156 and coworkers did the electrophoresis to study the changes of surface
electrical properties as a function of pH for the same cell lines, on a four-component equilibrium
model with a negligible variation between the experimental and theoretical charge in the pH
range of 2.5−9.0. In studying the mammalian cells, the pH was kept narrowly between 6 and 8,
which the cell membrane proteins can be maintained during the electrophoresis. The results
revealed that at a lower pH the charge density on the cancer cells surface gets more positive,
meaning more protonated. Their findings concluded that this increase is related to the acidic
(CTA) and basic (CTB) functional groups’ average association constant for hydroxyl ions (KOH) in
the breast cancer cell membrane, especially in MDA 231, which is higher than that in normal cell
(i.e. MCF10A) membrane.
From the plasma membrane proteomics,157 the cell membrane proteins are elevated in
MDA 231, comparing with the MCF7 and normal (MCF10A) cells, and the keratin type I
Cytoskeletal 17 (KRT17) is present only in the normal cell. As the cell turns malignant, this
cytoskeletal filament disappears i.e. being replaced by Keratin type I Cytoskeletal 19 (KRT19)
that was found to be higher in the MCF7 cell-membrane. Vimentin (VIM), a cytoskeletal
filament mostly expressed in mesenchymal stem cells, is highly expressed in the aggressive
cancer cell (MDA-MB231). Microtubule-interacting protein 1B (MAP1B) was only found in
MDA-MB231, while the subtype (MAP4) was found in both MCF7 and MCF10A. Myosin
regulatory light chain 12B (MYL12B), important in maintaining the cell structure, was found
only in MDA-MB231. Further, the MDA-MB231 have more cytoskeletal filaments and some are
abnormally expressed. These are important to cause the resistivity changes by e.g. lowering the
water content in the cell. These variations can be measured using the impedance to quantify the
mass-transfer outside the cells at low frequency and that across the cell membrane (e.g. into the
cytoplasm) at high frequency.
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Further, the lipid bilayer was investigated to show the cancer cell membrane with fewer
fatty acids and phospholipid types.158 Interestingly, that study found that cancer cells produce
more positively charged phospholipids, e.g. (PE 36:2) in MCF7 and (PC 32:0, PC 36:2, PI 36:1)
in MDA-MB231. Among the fatty acids, mostly are the oleic acid (C18:1) and palmitoleic acid
(C16:0) in MCF7, and the oleic acid (C18:0) and docosahexaenoic acid (C22:6) in MDAMB231. The presence of such unsaturated fatty acids within the cell-membrane bilayer increases
the cell membrane’s fluidity, flexibility, and permeability along with the pathological
malignancy of the cancer cell. Other studies reported an elevated phospholipid production in the
same cell-lines.156, 159, 160 This overproduction is often correlated to a tumorigenic transformation.
This is because in the tumor’s external microenvironment, the pH is more acidic (pH 6.5) hence
the cancer cell surface net-charge is more positive, as the surface carboxyl, amino and phosphate
groups are protonated. Therefore, increasing the number of cell surface phospholipids lead to a
more negative surface charge density at high pH but a more positive charge density at low pH.
In breast tumor, the sialic acid was lately found to be upregulated which affects the cell
membrane charge, and in turn the acid and basic groups on the cell membrane160. Thus, a knock
out to an important gene in the sialic acid metabolism disabled the production of the active form
of sialic acid and helped lower the lung cancer metastasis rate in vivo.161
In addition, the reactive oxygen species (ROS) can affect membrane lipids and proteins in
the acidic environment, via triggering a lipid peroxidation process. Consequently, phospholipids
in the inner lipid layer such as phosphatidylserine (PS) expose to the outside, thus-increasing
both the acid group’s content on the cell surface156, and the level of KBOH comparing with the
original cell-membrane.
All these reports in the literature consistently support that the transformation in cell
membrane structural lipid and protein composition can cause the increase in resistivity due to
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exposure of negatively charged groups. In turn, the higher resistivity can lower the cell’s outer
layer potential, which further increases the resistivity of the cancer cell membrane and supports
the selective quantitative cell-sensing and cell-type characterization.

6.2.2 1st impedance test for distinguishing breast cancer cells from colon cancer cells
An important question to be answered in this project is whether there is a difference in
the surface charge density of cancer cells developed in different part of the body, e.g. colon
cancer cells vs. breast cancer cells (Fig. 6.13). The breast cancer cells showed an increase in the
impedance level corresponding to the cell’s pathological malignancy. However, an opposite
response was observed from the same sensing of an aggressive colon cancer cell (HCT 116) on
the same set of the biosensors. This HCT 116 cell line has turned the nanowire-surface to be
more conducting from apparently a lower impedance level. With little being reported in literature
based on our thorough literature survey, the impedance data can guide future cell-biology study
on the proteins and lipids in the HCT116 cell’s membrane that are different than that in the
breast cancer cells’. Further, modifying the breast cancer cell line membrane’s protein and lipid
constitution may help tell what opposite charge density is in the HCT116 cell with, probably,
more amino groups on its surface at the experimental pH 7.4 being protonated to hold a positive
net surface charge thus-making the bioscaffold-nanowire to be more conducting. Since the
breast tissue (neutral) have different pH in nature than the colon (basic), the colon cancer cells
should easily adapt to the acidic environment generated by the tumor tissue.
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Figure 6.13: Impedance test for normal cell and different cancer cell types.

In the Nyquist plot (Fig. 6.14) with the real (ZRE) and imaginary (ZIM) parts of the complex
impedance, each cell-line has a characteristic impedance level. Unusually, an induction effect
exhibits clearly on every thus-made bioscaffold, due apparently to the nesting nanowires circularly
self-assembling into each nest. In other words, the current moves on each nanowire surface from
the bottom to the top of the nanowire in a circular manner for spirally electric field reaching the
surface of each nest, thus-creating an inductive electromagnetic field for the nano-induction effect.
This effect was not observed in pure Ti-metal working electrode, which means that the induction
is not generated from the leads (Fig. 6.15).

60

Nyquist plot
HCT 116

Base (TiO2)

MCF10

MCF 7

MDA 231

-26
-21
Z imag

-16

Low
frequency

-11
-6
-1

20

30

40

50

60

70

80

90

100

4
High
frequency

9
14

Induction

Z real

Figure 6.14: Nyquist plot for TiO2, normal (MCF10A), and three different cancer cell lines.
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Figure 6.15: Nyquist plot for Titanium metal.
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6.2.3 Impedance test for breast cancer cell and normal cell lines in different mixing ratios
This work aims to study how the impedance signal would change when the breast cancer
cells and normal cells be mixed together. In this experiment, the MCF10A normal cells were mixed
with the MCF7 and MDA 231 cancer cells, respectively, each across a wide range of mixing ratios,
from 1:1,00 to 1:5 (Fig. 6.16). In the Fig. 6.16, a linear correlation between the lower mixing ratio
and the higher corresponding impedance can help quantify how many cancer cells being mixed in
the normal cells. This method, if combined with a simple cytofluorometry (for knowing the total
number of cells), can be useful to detect the CTCs in a mixture with other cells, because other lab
reported a 5% increase of the impedance from one cancer cell in 100 normal cells.58
In literature, a study on these three cell-lines correlated a lower capacity with a higher
malignance, due to the increase in the cell permeability for the pathologically more aggressive
cancer cell.60 An electrophoresis study on the same three cell-lines showed significant differences
in the cell membrane net-charge, showing cancer cells’ more negative electric properties towards
negativity more than observed in normal cells.156 These reports match our study, co-suggesting
that our label-free nano-EIS sensor can distinguish normal from cancer cells, and differentiate the
pathological malignance stages from early to late cancer progression.
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Figure 6.16: Impedance at 1 MHz for mixed sample.
6.2.4 1st impedance test for the Warburg effect on breast cancer and colon cancer
cell-lines
The aim of this experiment is to quantify the effect of an electrically neutral metabolic fuel
on the cancer cells, which is underexploited so far on an electrochemical nanosensor, but useful
for quantifying and even characterizing cancer metabolic wastes, which is important in the basic
cancer biology. In Fig. 6.17, the cancer cells shifted their impedance level from above to below
the base line differently from the normal cells, indicating that the normal and cancer cells secret
different metabolic wastes each in a unique charge density to affect the nanowire-surface charge
uniquely.
As discussed in the Chapter 2, cancer cells consume glucose and secrete lactic acid as a
metabolic waste (i.e. Warburg effect), with a consistent upregulation of genes for the glucose
transport and glycolysis,15-17 and the glucose transporters overexpress in hepatocarcinomas as
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well.18-20 By consuming more glucose than individual cancer cells, a tumor secretes a massive
amount of lactate aiming to toxify the nearby normal cells more intensively, which can potentially
result in a much stronger impedance signal on our bioscaffold sensor.
In cancer biology, under the help of overexpressed GLUT-1 that is activated by the HIF1protein, cancer cells tend to have a higher intake of glucose results in more production and
secretion of the negative-charged lactic acids. Thus-increased [H+] on the nearby nanowire surface
and increased in he nanowire-surface conductivity and lowered the impedance level, which is
supported by the pH study in the Fig. 6.7. The MCF7 and MDA 231 cancer cells each showed a
significant shifting (Fig. 6.17) in their impedance level (see the red and blue arrows) after allowing
the cells to intake the glucose, thus-proving the Warburg effect for quantifying and characterizing
the cancer and normal cells directly on our smart bioscaffold-turned nanobiosensor.
In general, different types of cancer cells may secret different metabolic wastes as the
biomarkers. For example, the HCT 116 cells metabolism162 from an increase in the 𝛽-oxidation
and urea cycle metabolism secrets four main metabolic wastes: N-acetylputrescine,
Phenylacetylglycine, Deoxycarnitine or gamma-butyrobetaine (GBB), and Butyrylcarnitine.162
These four metabolites each has an amide group in the structure. This explains why HCT 116 act
differently from other breast cancer cells on the titanate nanowire-bioscaffold. Overall, different
cancer cells secrete different metabolite wastes as the cell’s biomarker that if showing a charge in
water can help quantify and characterize the cells on the titanate-nanowire bioscaffold-nanosensor.
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Figure 6.17: (a) Impedance test for different cancer cell lines with no glucose in 1xPBS. (b)
Impedance test for cancer cells compared to normal cell incubated with 1xPBS+ 5.5mM glucose.
P value for MCF7 and MDA 231 is < 10-80.
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6.2.5 Impedance test for the temperature effect on the breast cancer cell lines at
37℃
The abovementioned impedance tests done at room temperature (25℃) have raised a
question regarding whether, and if yes how, the temperature that affects the cancer cell
metabolism would change the impedance level at human body temperature 37oC? In this
experiment, the MCF7 and MDA 231 cells were attached on the bioscaffold, respectively over
35 minutes at 37oC , and the impedance tests were done at the same tempreture. The impedance
level for MCF7 and MDA 231 breast cell lines show no significant shifting in impedance signal
intensity (Fig 6.18).
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Figure 6.18: Impedance level of MCF7 and MDA 231 at 37℃
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6.2.6 1st impedance test for the doxorubicin drug effect on the breast cancer cell
lines
Doxorubicin (DOX, in a chemical formula of C27H29NO11), also called AdriamycinTM, is a
popular chemotherapy drug for treating several types of cancer including breast cancer via
triggering the cancer cell death. This drug was used to quantify the drug effect on breast cancer
cells’ metabolism in response to stresses from different dosages of the DOX, via monitoring the
impedance signal change from the cancer cells before and after the DOX treatment. The drug
cytotoxicity was assessed to determine the concentration of 2.0 (µM), which the cancer cells start
to die in a proper pace that can enable us to quantitatively characterize the DOX effect on the
cancer cell’s metabolism and apoptosis directly on the smart bioscaffold (Fig. 6.19).
The DOX is supposed to decrease the MCF 7 impedance due to cell’s resistance to the
DOX.163, 164 This is because the overexpressed P-glycoprotein 1 (P-gp), also called multidrug
resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1) or
cluster of differentiation 243 (CD243), can pump the foreign molecules out of the MCF 7 cell.165
Due to MCF7 cell’s resistance to DOX, incubating MCF7 with glucose helped MCF7 cell
to flush the pre-absorbed DOX out to the extracellular solution, which should result in a higher
impedance on the bioscaffold at low frequency due to the DOX negative in charge at
physiological pH 7.4 (Fig. 6.20). In contrast, the MDA 231 cells, with a much lower resistance to
DOX, should show a lower impedance under the same condition, and no significant response to
glucose after being pre-treated with DOX (Fig. 6.21).
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Figure 6.19: Microscopic image to drug treated MCF7 in cell culture compared to control.
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Figure 6.20: (a) Impedance test for MCF7 treated with DOX for 24 and 48 hours. (b) Impedance
test for MCF7 treated with DOX for 24 hrs and then incubated with glucose for 35 minutes
before performing the test.
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Figure 6.21: Impedance test of MDA-MB231 treated with DOX for 24hours and being
incubated with glucose before the test.
6.3 Checking the cell attachment under the optical microscope
Before and after the impedance, the normal and cancerous cells on the bioscaffold were
checked under the optical microscope. As can be seen in the Fig. 6.23, the cells population
change on the bioscaffold was negligible, which supports why the impedance cell-sensing was
kept within the 35 minutes.
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Figure 6.22: Optical microscopic images of the cells on bioscaffold. (a). without stain; (b). with
fluorescent stain (b).
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Chapter 7. Conclusion
The bioscaffold sensor can differentiate the pathological stage for the benign and malignant
cancer cells. The different cancer cells from different origins (e.g. colon cancer vs. breast cancer)
showed different impedance responses upon binding and metabolizing to the nanowire surface, to
date never reported in literature, which will help collect new data for advancing the cancer biology.
Mixing cancer cells with normal cells over a wide range has further validated this new cell-sensing
technology. Quantifying the cancer drug’s efficacy has been ongoing using other drugs old and
new to the market. The sensing for the glucose effect showed a partial reversibility of the cancerdrug effect different for different types of the cancer cells. On this basis, the characteristic
fingerprints of cancer cells have been concluded in the Fig.7.1 for MCF7 cells, and in the Fig.7.2
for the MDA-MB231, which may change the game in today’s cancer-pathology labs, via thussensing other cells on the smart-bioscaffold.
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Figure 7.1: MCF7 characterization
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Figure 7.2: MDA-MB231 characterization.
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Chapter 8. Future work

The findings from the experiments that are summarized in this dissertation have urged us to
propose some low-risk, high-gain future work in the following:
1- To determine the impedance of more shapes, sizes and types on the smart bioscaffold.
2- To improve the sensitivity of the bioscaffold to the highest toward detecting single (or
single digit) cell(s).
3- To expand the impedance sensing technology to covering all kinds of charge species
besides the biological cells.
4- To study the impedance of tissues, bacteria, virus, eggs, and live insects on the
bioscaffolds.
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